These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 9536019
1. Characterization of human neutrophil and endothelial cell ligand-operated extracellular acidification rate by microphysiometry: impact of reoxygenation. Gronert K, Colgan SP, Serhan CN. J Pharmacol Exp Ther; 1998 Apr; 285(1):252-61. PubMed ID: 9536019 [Abstract] [Full Text] [Related]
2. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. Papayianni A, Serhan CN, Brady HR. J Immunol; 1996 Mar 15; 156(6):2264-72. PubMed ID: 8690917 [Abstract] [Full Text] [Related]
3. Lipoxin A4 and lipoxin B4 stimulate the release but not the oxygenation of arachidonic acid in human neutrophils: dissociation between lipid remodeling and adhesion. Nigam S, Fiore S, Luscinskas FW, Serhan CN. J Cell Physiol; 1990 Jun 15; 143(3):512-23. PubMed ID: 2162850 [Abstract] [Full Text] [Related]
4. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization. Romano M, Maddox JF, Serhan CN. J Immunol; 1996 Sep 01; 157(5):2149-54. PubMed ID: 8757340 [Abstract] [Full Text] [Related]
5. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. Takano T, Clish CB, Gronert K, Petasis N, Serhan CN. J Clin Invest; 1998 Feb 15; 101(4):819-26. PubMed ID: 9466977 [Abstract] [Full Text] [Related]
6. Mechanisms for lipoxin A4-induced neutrophil-dependent cytotoxicity for human endothelial cells. Bratt J, Lerner R, Ringertz B, Palmblad J. J Lab Clin Med; 1995 Jul 15; 126(1):36-43. PubMed ID: 7602232 [Abstract] [Full Text] [Related]
7. Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Lee TH, Horton CE, Kyan-Aung U, Haskard D, Crea AE, Spur BW. Clin Sci (Lond); 1989 Aug 15; 77(2):195-203. PubMed ID: 2548801 [Abstract] [Full Text] [Related]
8. Mechanisms for lipoxin A4 induced neutrophil dependent cytotoxicity for human endothelial cells. Bratt J, Lerner R, Ringertz B, Palmblad J. Adv Prostaglandin Thromboxane Leukot Res; 1995 Aug 15; 23():419-21. PubMed ID: 7732886 [No Abstract] [Full Text] [Related]
9. Human endothelial cells inhibit granulocyte aggregation in vitro. Zimmerman GA, Klein-Knoeckel D. J Immunol; 1986 May 15; 136(10):3839-47. PubMed ID: 3009611 [Abstract] [Full Text] [Related]
10. Sequential morphologic events during apoptosis of human neutrophils. Modulation by lipoxygenase-derived eicosanoids. Hébert MJ, Takano T, Holthöfer H, Brady HR. J Immunol; 1996 Oct 01; 157(7):3105-15. PubMed ID: 8816421 [Abstract] [Full Text] [Related]
11. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils. Bae YS, Park JC, He R, Ye RD, Kwak JY, Suh PG, Ho Ryu S. Mol Pharmacol; 2003 Sep 01; 64(3):721-30. PubMed ID: 12920210 [Abstract] [Full Text] [Related]
12. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis. O'Meara YM, Brady HR. Kidney Int Suppl; 1997 Mar 01; 58():S56-61. PubMed ID: 9067945 [Abstract] [Full Text] [Related]
13. Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction. Fiore S, Serhan CN. Biochemistry; 1995 Dec 26; 34(51):16678-86. PubMed ID: 8527441 [Abstract] [Full Text] [Related]
14. Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE. O'Flaherty JT. J Cell Physiol; 1985 Feb 26; 122(2):229-39. PubMed ID: 2981891 [Abstract] [Full Text] [Related]
15. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils. Qiu FH, Devchand PR, Wada K, Serhan CN. FASEB J; 2001 Dec 26; 15(14):2736-8. PubMed ID: 11687510 [Abstract] [Full Text] [Related]
16. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment. Fletcher MP. J Immunol; 1986 Jun 01; 136(11):4213-9. PubMed ID: 3009618 [Abstract] [Full Text] [Related]
17. Leukotriene B4 modulates in vivo expression of delayed-type hypersensitivity by a receptor-mediated mechanism: regulation by lipoxin A4. Feng Z, Godfrey HP, Mandy S, Strudwick S, Lin KT, Heilman E, Wong PY. J Pharmacol Exp Ther; 1996 Aug 01; 278(2):950-6. PubMed ID: 8768752 [Abstract] [Full Text] [Related]
18. The tumor necrosis factor receptor and human neutrophil function. Deactivation and cross-deactivation of tumor necrosis factor-induced neutrophil responses by receptor down-regulation. Schleiffenbaum B, Fehr J. J Clin Invest; 1990 Jul 01; 86(1):184-95. PubMed ID: 2164042 [Abstract] [Full Text] [Related]
19. Lipoxin A4 induces hyperadhesiveness in human endothelial cells for neutrophils. Lerner R, Heimburger M, Palmblad J. Blood; 1993 Aug 01; 82(3):948-53. PubMed ID: 8393356 [Abstract] [Full Text] [Related]
20. Characterization of lipoxins by combined gas chromatography and electron-capture negative ion chemical ionization mass spectrometry: formation of lipoxin A4 by stimulated human whole blood. Brezinski DA, Serhan CN. Biol Mass Spectrom; 1991 Feb 01; 20(2):45-52. PubMed ID: 1883860 [Abstract] [Full Text] [Related] Page: [Next] [New Search]